Effect of pregnane X receptor expression on drug resistance in breast cancer

Qiao,En‑Qi; Yang,Hong‑Jian

doi:10.3892/ol.2014.1817

Effect of pregnane X receptor expression on drug resistance in breast cancer

Authors:
- En‑Qi Qiao
- Hong‑Jian Yang
View Affiliations

Affiliations: Department of Oncological Surgery, Zhejiang Cancer Hospital, Hangzhou, Zhejiang 310022, P.R. China
Published online on: January 22, 2014 https://doi.org/10.3892/ol.2014.1817
Pages: 1191-1196

Metrics: Total Views: 0 (Spandidos Publications: | PMC Statistics: )

Metrics: Total PDF Downloads: 0 (Spandidos Publications: | PMC Statistics: )

Cited By (CrossRef): 0 citations Loading Articles...

Abstract

This study was conducted to investigate the effect of increased expression of the nuclear transcription factor receptor pregnane X receptor (PXR) on drug resistance of breast cancer cells. Western blotting was used to detect the expression of PXR in breast carcinoma cells. The PXR agonist SR12813 was used to upregulate the expression of PXR. Semi‑quantitative polymerase chain reaction was used to detect PXR gene expression in normal and cancerous breast tissues, as well as the expression levels of the drug‑resistant genes multidrug resistance protein 1 (MDR1) and breast cancer resistance protein (BCRP) in breast cancer cells. A Cell Counting Kit‑8 assay was used to observe the sensitivity of the breast cancer cells to chemotherapeutic agents. Flow cytometry was used to investigate cell apoptosis. PXR expression was detected in normal and cancerous human breast tissues and in breast cancer cell lines. SR12813 treatment led to an increased expression of PXR protein and an increased expression of drug‑resistant genes, MDR1 and BCRP, in MCF‑7 and MDA‑MB‑231 cells. SR12813 pretreatment significantly increased the resistance of MDA‑MB‑231 cells to docetaxel. A marked increase in resistance to 4‑hydroxytamoxifen was also observed in MCF‑7 with SR12813 pretreatment. Additionally, we also found that pretreatment with SR12813 led to reduced apoptosis of the two cell strains induced by chemotherapeutic agents. In conclusion, PXR expression has an important effect on the sensitivity to chemotherapy of PXR‑positive breast carcinoma. The inhibitory effect of PXR on cell apoptosis may contribute to the drug resistance of breast carcinoma.

View Figures

View References

1	Jemal A, Bray F, Center MM, Ferlay J, Ward E and Forman D: Global cancer statistics. CA Cancer J Clin. 61:69–90. 2011. View Article : Google Scholar
2	Leonessa F and Clarke R: ATP binding cassette transporters and drug resistance in breast cancer. Endocr Relat Cancer. 10:43–73. 2003. View Article : Google Scholar : PubMed/NCBI
3	Kliewer SA, Moore JT, Wade L, et al: An orphan nuclear receptor activated by pregnanes defines a novel steroid signaling pathway. Cell. 92:73–82. 1998. View Article : Google Scholar
4	Minemura M, Tanimura H and Tabor E: Overexpression of multidrug resistance genes MDR1 and cMOAT in human hepatocellular carcinoma and hepatoblastoma cell lines. Int J Oncol. 15:559–563. 1999.PubMed/NCBI
5	Tolson AH and Wang H: Regulation of drug-metabolizing enzymes by xenobiotic receptors: PXR and CAR. Adv Drug Deliv Rev. 62:1238–1249. 2010. View Article : Google Scholar : PubMed/NCBI
6	Chen T: Overcoming drug resistance by regulating nuclear receptors. Adv Drug Deliv Rev. 62:1257–1264. 2010. View Article : Google Scholar : PubMed/NCBI
7	Campa D, Butterbach K, Nieters A, et al: A comprehensive study of polymorphisms in the ABCB1, ABCC2, ABCG2, NR1I2 genes and lymphoma risk. Int J Cancer. 131:803–812. 2012. View Article : Google Scholar : PubMed/NCBI
8	Heid CA, Stevens J, Livak KJ and Williams PM: Real time quantitative PCR. Genome Res. 6:986–994. 1996. View Article : Google Scholar : PubMed/NCBI
9	Mellor HR and Callaghan R: Resistance to chemotherapy in cancer: a complex and integrated cellular response. Pharmacology. 81:275–300. 2008. View Article : Google Scholar : PubMed/NCBI
10	Navarro G, Sawant RR, Biswas S, Essex S, Tros de Ilarduya C and Torchilin VP: P-glycoprotein silencing with siRNA delivered by DOPE-modified PEI overcomes doxorubicin resistance in breast cancer cells. Nanomedicine (Lond). 7:65–78. 2012. View Article : Google Scholar : PubMed/NCBI
11	Yuan JH, Cheng JQ, Zhuang ZX, et al: Study on the relationship between breast cancer resistance protein expression and 5-fluorouracil resistance. Zhonghua Yu Fang Yi Xue Za Zhi. 42:506–510. 2008.(In Chinese).
12	Liu X, Chen P, Cui J and Zhang G: Expression of drug resistance related proteins in breast cancer tissues and its relationship with chemotherapy therapeutic effect. Chin J Cancer Prev Treatment. 18:1354–1357. 2011.
13	Chen Y, Nie D, Wang MT, et al: Human pregnane X receptor and resistance to chemotherapy in prostate cancer. Cancer Res. 67:10361–10367. 2007. View Article : Google Scholar : PubMed/NCBI
14	Raynal C, Evrard A, Kantar J, et al: Pregnane X receptor (PXR) expression in colorectal cancer cells restricts irinotecan chemosensitivity through enhanced SN-38 glucuronidation. Mol Cancer. 9:462010. View Article : Google Scholar
15	Dotzlaw H, Leygue E, Watson P and Murphy LC: The human orphan receptor PXR messenger RNA is expressed in both normal and neoplastic breast tissue. Clin Cancer Res. 5:2103–2107. 1999.
16	Conde I, Lobo MV, Zamora J, et al: Human pregnane X receptor is expressed in breast carcinomas, potential heterodimers formation between hPXR and RXR-alpha. BMC Cancer. 8:1742008. View Article : Google Scholar
17	Meyer zu Schwabedissen HE, Tirona RG, Yip CS, et al: Interplay between the nuclear receptor pregnane X receptor and the uptake transporter organic anion transporter polypeptide 1A2 selectively enhances estrogen effects in breast cancer. Cancer Res. 68:9338–9347. 2008.
18	Chen Y, Tang Y, Chen S and Nie D: Regulation of drug resistance by human pregnane X receptor in breast cancer. Cancer Biol Ther. 8:1265–1272. 2009. View Article : Google Scholar : PubMed/NCBI
19	Jiang H, Chen W, Chen K, He J and Liang H: Roles of pregnane X receptor for proliferation and drug resistance in human colon cancer cells. Prog Mod Biomed. 9:2012–2015. 2009.
20	Honorat M, Mesnier A, Di Pietro A, et al: Dexamethasone down-regulates ABCG2 expression levels in breast cancer cells. Biochem Biophys Res Commun. 375:308–314. 2008. View Article : Google Scholar : PubMed/NCBI
21	Masuyama H, Nakatsukasa H, Takamoto N and Hiramatsu Y: Down-regulation of pregnane X receptor contributes to cell growth inhibition and apoptosis by anticancer agents in endometrial cancer cells. Mol Pharmacol. 72:1045–1053. 2007. View Article : Google Scholar : PubMed/NCBI
22	Wang H, Venkatesh M, Li H, et al: Pregnane X receptor activation induces FGF19-dependent tumor aggressiveness in humans and mice. J Clin Invest. 121:3220–3232. 2011. View Article : Google Scholar
23	Liu C, Li J, Wang L, et al: Analysis of tanshinone IIA induced cellular apoptosis in leukemia cells by genome-wide expression profiling. BMC Complement Altern Med. 12:52012. View Article : Google Scholar : PubMed/NCBI